COMMITMENTS AND CONTINGENCIES (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Aug. 20, 2020 |
Dec. 31, 2020 |
|
| Deferred underwriting fee payable | $ 7,500,000 | |
| Sponsor | Class B ordinary shares | ||
| Forfeiture of founder shares (in shares) | 375,000 | |
| Forfeiture of founder shares | $ 0 | |
| Over-allotment | ||
| Number of shares issued | 1,500,000 | |
| Underwriting discount per unit | $ 0.20 | |
| Cash underwriting fees | $ 4,300,000 | |
| Deferred fee per unit | $ 0.35 |
| X | ||||||||||
- Definition Represents the cash underwriting discount per unit. No definition available.
|
| X | ||||||||||
- Definition Represents the deferred fee per unit. No definition available.
|
| X | ||||||||||
- Definition The carrying value as of balance sheet date of underwriting compensation deferred, classified as noncurrent. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of underwriting fees incurred on sale of stock. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of stock bought back by the entity at the exercise price or redemption price. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of stock bought back by the entity at the exercise price or redemption price. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|